(Q53564593)

15 May 2018

title

Immunostaining of phospho-histone H3 and Ki-67 improves reproducibility of recurrence risk assessment of gastrointestinal stromal tumors. (English)

1 reference

15 May 2018

1 reference

Arnaud Uguen

1

1 reference

15 May 2018

Gwenaël Conq

2

1 reference

15 May 2018

Laurent Doucet

3

1 reference

15 May 2018

Matthieu Talagas

4

1 reference

15 May 2018

Sebastian Costa

5

1 reference

15 May 2018

Marc De Braekeleer

6

1 reference

15 May 2018

Pascale Marcorelles

7

1 reference

15 May 2018

publication date

1 April 2015

1 reference

15 May 2018

published in

Virchows Archiv

1 reference

15 May 2018

volume

467

1 reference

15 May 2018

issue

1

1 reference

15 May 2018

page(s)

47-54

1 reference

15 May 2018

https://scigraph.springernature.com/pub.10.1007/s00428-015-1763-2

exact match

0 references

cites work

Gastrointestinal stromal tumors in Iceland, 1990-2003: the icelandic GIST study, a population-based incidence and pathologic risk stratification study.

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1763-2

W/kit gene required for interstitial cells of Cajal and for intestinal pacemaker activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1763-2

PDGFRA mutations in gastrointestinal stromal tumors: frequency, spectrum and in vitro sensitivity to imatinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1763-2

KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1763-2

DOG1 and CD117 are the antibodies of choice in the diagnosis of gastrointestinal stromal tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1763-2

Diagnosis of gastrointestinal stromal tumors: a consensus approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1763-2

Risk stratification of patients diagnosed with gastrointestinal stromal tumor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1763-2

Gastrointestinal stromal tumors: pathology and prognosis at different sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1763-2

Adjuvant therapy of gastrointestinal stromal tumors (GIST).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1763-2

Adjuvant therapy in primary GIST: state-of-the-art

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1763-2

An international Ki67 reproducibility study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1763-2

Interobserver variability in histologic recognition, interpretation of KIT immunostaining, and determining MIB-1 labeling indices in gastrointestinal stromal tumors and other spindle cell tumors of the gastrointestinal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1763-2

Assessment and prognostic significance of mitotic index using the mitosis marker phospho-histone H3 in low and intermediate-grade infiltrating astrocytomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1763-2

Comparative diagnostic and prognostic performances of the hematoxylin-eosin and phospho-histone H3 mitotic count and Ki-67 index in adrenocortical carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1763-2

Sensitivity and usefulness of anti-phosphohistone-H3 antibody immunostaining for counting mitotic figures in meningioma cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1763-2

Mitotic rate in melanoma: prognostic value of immunostaining and computer-assisted image analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1763-2

Phosphohistone H3 expression has much stronger prognostic value than classical prognosticators in invasive lymph node-negative breast cancer patients less than 55 years of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1763-2

Mitosis-specific marker phospho-histone H3 in the assessment of mitotic index in uterine smooth muscle tumors: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1763-2

Mitosis-specific phosphorylation of histone H3 initiates primarily within pericentromeric heterochromatin during G2 and spreads in an ordered fashion coincident with mitotic chromosome condensation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1763-2

Histone H3 phosphorylation and expression of cyclins A and B1 measured in individual cells during their progression through G2 and mitosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1763-2

Phosphohistone-H3 and Ki-67 immunostaining in cutaneous pilar leiomyoma and leiomyosarcoma (atypical intradermal smooth muscle neoplasm).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1763-2

Evaluation of malignancy using Ki-67, p53, EGFR and COX-2 expressions in gastrointestinal stromal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1763-2

Prognostic significance of PTEN, Ki-67 and CD44s expression patterns in gastrointestinal stromal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1763-2

Observer reliability in assessment of mitotic activity and MIB-1-determined proliferation rate in pediatric sarcomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1763-2

Gastrointestinal stromal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1763-2

Immunohistochemical assessment of mitotic count in uveal melanoma

21 January 2018

1 reference

12 December 2020

Using the mitosis-specific marker anti-phosphohistone H3 to assess mitosis in pulmonary neuroendocrine carcinomas

1 reference

12 December 2020

Useof anti-phosphohistone H3 immunohistochemistry to determine mitotic rate in thin melanoma

1 reference

12 December 2020

Chromatin condensation is not associated with apoptosis

1 reference

12 December 2020

Validity and reproducibility of histologic diagnosis and grading for adult soft-tissue sarcomas

1 reference

12 December 2020

Gastrointestinal stromal tumours: origin and molecular oncology.

1 reference

12 December 2020

KIT activation is a ubiquitous feature of gastrointestinal stromal tumors

1 reference

12 December 2020

Robust linear regression model of Ki-67 for mitotic rate in gastrointestinal stromal tumors.

1 reference

12 December 2020

10.1007/S00428-015-1763-2

Identifiers

DOI

1 reference

15 May 2018

1 reference

15 May 2018